Imunon, Inc. Operating Leases, Future Minimum Payments, Due in Rolling after Year Five
Imunon, Inc. (IMNN) had Operating Leases, Future Minimum Payments, Due in Rolling after Year Five of $249.10 thousand as of 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive · last filed 2012-08-14
- 2012-06-30: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $249.10K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling after Year Five |
|---|---|
| 2012-06-30 | $249.10K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |